Stocks · News reference
Bionano Genomics Q2 Sales $8.171M Beat $7.476M Estimate
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ:BNGO) raises FY2026 sales outlook from $30.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.137 million estimate.
Bionano Genomics Sees Q3 Sales $8.200M-$8.600M vs $8.575M Est
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $8.200 million-$8.600 million vs $8.575 million analyst estimate.